About PharmaResources

PharmaResources was founded in 2007 as a one-stop integrated service provider for new drug development and commercial production, committed to drug discovery, pharmaceutical process research and development, and commercial production of APIs and intermediates.

Scroll down to browse

About PharmaResources

PharmaResources was founded in 2007 as a one-stop integrated service provider for new drug development and commercial production, committed to drug discovery, pharmaceutical process research and development, and commercial production of APIs and intermediates.

The company’s new drug development services cover the entire process of preclinical new drug research, mainly including drug discovery and process research and development services. In particular, drug discovery service helps customers design, screen and optimize hit compounds and lead compounds, coupled with structural improvement and preliminary safety screening, to obtain candidate compounds with intellectual property rights and excellent druggability. Process research and development service provides new drug process chemistry services and innovative synthetic process development for pharmaceutical companies around the world, helping customers to achieve cost-effective, safe, green and reliable commercial production of intermediates and APIs in scales from kilograms to tons. Relying on its own advantages in pharmaceutical technology, the company is also engaged in customized production services of key intermediates for new drugs, as well as independent development and production of specialty API intermediates with complex chemical structures and high synthesis difficulties.

In March 2021, the company’s IPO application for GEM board was accepted by Shenzhen Stock Exchange, and in April 2022, it passed the examination of the Listing Committee. On July 8, 2022, the China Securities Regulatory Commission approved the application of PharmaResources (Shanghai) Co., Ltd. for initial public offering of shares and listing on Shenzhen GEM. On October 18, 2022, PharmaResources made an initial public offering of 19.25 million A shares and was listed on the GEM board.

As the company’s core value “science-focused with continuous innovation” advocates, “science and innovation” is always the target of the company and all members of PharmaResources, despite of any changes in the internal and external environment. Only by constantly pursuing excellence in science and technological innovation can we meet the ever-changing needs of our customers and the market, while ensuring the sustainable competitiveness of the company.

Company locations

Location
PharmaResources provides global pharmaceutical customers with one-stop services for the development and manufacturing of small molecule innovative drugs.
The company is headquartered in Shanghai.

Services

  • Drug
    discovery
  • Process
    discovery
  • Pharmaceutical
    study
  • Drug
    production

    Founder team

    Team of founders

    Chen PingPhD

    General Manager, Chairman, Founder of PharmaResources (Shanghai)

    Bachelor of Science, Peking University; PhD, Duke University; Postdoctoral Fellow, University of Montreal, Canada

    Senior Chief Scientist of Bristol-Myers Squibb (17 years), principal inventor of dasatinib, a new drug for chronic myeloid leukemia

    Laureate of the “Thomas A. Edison Patent Award” granted by the Research & Development Council of New Jersey in 2008

    Having published 40+ SCI scientific papers and filed ~35 PCT invention patents (including 28 granted)

    Expert of the 6th “National Thousand Talents Plan”, expert judge of the 2017 “Major New Drug Creation” Science and Technology Major Project of the National Health Commission

    Jiang ShengliEMBA

    Director/Secretary to the Board, Deputy General Manager,
    Founder of PharmaResources (Shanghai)

    Bachelor of Science, Sichuan University, Executive MBA from China Europe International Business School

    Previous technical and managerial positions including engineer, chief engineer, general manager in several pharmaceutical companies, with extensive experience in process development and production scale-up

    Laureate of the first prize of Science and Technology Award of Zhejiang Province in 2002 and the third prize of Science and Technology Award of Zhejiang Province in 2003

    Having filed 8 invention patents (including 4 granted)

    An Rongchang

    Director, Founder of PharmaResources (Kaiyuan)

    Bachelor of Science, Fudan University, MBA, Suffolk University, Boston, USA (in progress)

    Having 34 years of working experience in the industry including Northeast Pharmaceutical General Factory and Shenyang Dongyu Chemical Co., Ltd.

    Founder of Kaiyuan Hengtai Nutrition Co., Ltd.

    Founder of Zhejiang Anglitai Pharmaceutical Manufacturing Co., Ltd.

    1 / 3
    • Chen PingPhD
    • Jiang ShengliEMBA
    • An Rongchang

    Core management team

    Core management team
    • Cai Zhenwei PhD

      Executive Vice President / Medicinal Chemistry

      Rutgers University, USA

      PhD in Medicinal Chemistry
      30 years of working experience
    • Xu Zhongmin

      Senior Vice President / Process Development

      Boston College, USA

      PhD in Organic Chemistry
      30 years of working experience
    • Li Haifeng MS

      Deputy General Manager / EHS

      Fudan University

      Master of Chemical Engineering
      21 years of working experience
    • Zhang Yuan MS

      Vice President/Business Development

      University of Frankfurt, Germany

      Master of Science in Biology
      23 years of working experience
    • Li Shicheng BS

      Chief Financial Officer

      Shanghai University of Finance and Economics

      Bachelor of Science in Accounting
      20 years of working experience
    • Tang Kaiyong PhD

      Vice President / Pharmaceutical Research

      East China Normal University

      PhD in Organic Chemistry
      16 years of working experience
    • Li Juan PhD

      Executive Deputy General Manager
      Kaiyuan PharmaResources (Factory)

      Shenyang Pharmaceutical University

      PhD in Medicinal Chemistry
      16 years of working experience

    Milestones

    Development course

    Partners

    Cooperative partner

    Corporate culture

    Enterprise culture
    • Our Mission

      To support drug discovery and benefit human health

    • Our Vision

      To build a one-stop integrated service platform for drug development and production

    • Our Values

      Science-focused, continuous innovation, integrity and efficiency, cooperation and dedication

    • Address

      Bldg. 12, No. 59 Kai Qing Rd, Pudong, Shanghai (West Campus)

      Bldg. 7, No. 509 Ren Qing Rd, Pudong, Shanghai (East Campus)

    • Service Hotline

      +86-21-50720228-202

    • Email

      sales@pharmaresources.cn

      We will give you reply as soon as possible.

    Copyright © Copyright 2023 PharmaResources (Shanghai) Co., Ltd. (Official Website)

    Reference No: 沪ICP备20013779号 Website Constructed by:Ocean Shanghai